Patient characteristics and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban or vitamin K antagonists: real-world evidence from Italian administrative databases.
CONCLUSION: In this analysis, apixaban was associated with a lower risk of major bleeding compared with VKA.
PMID: 30101611 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Atrial Fibrillation | Bleeding | Databases & Libraries | General Medicine | Italy Health | Study | Vitamin K | Vitamins